Carcinoma, Non-Small-Cell Lung: all 6,641 studies
Page 14 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.
- Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental ResearchRecruitingNCT05669105
- Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLCRecruitingNCT05668650Phase 3
- Phase Ⅱ/Ⅲ Clinical Study of Tumor Treating Fields （EFE-P100）Combined With Docetaxel in the Treatment of Stage IV Non-small Cell Lung Cancer Patients With Disease Progression After Platinum-based Chemotherapy and Anti-programmed Death 1（PD-1)/Programmed Cell Death-Ligand 1(PD-L1) Antibody TreatmentNot yet recruitingNCT05661240Phase 2/3
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT05657873Phase 2
- A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung CancerRecruitingNCT05654454Phase 3
- Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer TreatmentRecruitingNCT05648955Early Phase 1
- Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving SurgeryRecruitingNCT05648370
- First-Line Treatment for Advanced Non-squamous Non-Small-Cell Lung Cancer With Negative Driver Gene: a Single-center, Single-Arm TrialRecruitingNCT05648071Phase 3
- SBRT/RT in Oligometastatic Stage IV NSCLCRecruitingNCT05647590Not applicable
- Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)RecruitingNCT05642572Phase 2
- A Phase Ib/II Clinical Trial to Evaluate the Safety and Efficacy of HLX208+HLX10 in NSCLC With BRAF V600E MutationRecruitingNCT05641493Phase 1/2
- Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain MetastasesRecruitingNCT05638425
- Multimodal Prehabilitation in Patients With Lung Cancer Undergoing Neoadjuvant TherapyRecruitingNCT05636969Not applicable
- Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12CRecruitingNCT05631249Phase 2
- TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVORecruitingNCT05628376
- First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor MalignanciesRecruitingNCT05627960Phase 1
- Autologous CAR T-Cells Targeting the GD2 Antigen for Lung CancerRecruitingNCT05620342Early Phase 1
- Carbon Ion Therapy for Peripheral Non-small Cell Lung CancerRecruitingNCT05613452Phase 2
- PROspective Trial on EOsinophilia in Non-Small Cell Lung Cancer (NSCLC).RecruitingNCT05602259Not applicable
- Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)RecruitingNCT05598528
- A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsRecruitingNCT05592626Phase 1/2
- Pembrolizumab for Advanced NSCLC and PS 2-3RecruitingNCT05589818Phase 2
- SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLCNot yet recruitingNCT05583409Not applicable
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)RecruitingNCT05579366Phase 1/2
- Pamiparib (BGB-290) Was Used in EGFR-TkIs Resistant Non-small Cell Lung CancerRecruitingNCT05573373Phase 1
- SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung CancerRecruitingNCT05570825Phase 2
- Assessing an Oral EGFR Inhibitor, DZD9008 in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) With EGFR Mutations (WU-KONG15)RecruitingNCT05559645Not applicable
- Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung CancerRecruitingNCT05557552Not applicable
- To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR MutationRecruitingNCT05555212Phase 1
- H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLCRecruitingNCT05552781Phase 1/2
- APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational ReaserchRecruitingNCT05550961
- First-line Furmonertinib in Advanced NSCLC Patients With EGFR Uncommon MutationRecruitingNCT05548348Phase 2
- A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLCRecruitingNCT05543330Phase 1/2
- PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN StudyRecruitingNCT05542485
- The Use of Molecular Radiogenomics in Non-small Cell Lung CancerRecruitingNCT05541744
- I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With ImmunotherapyRecruitingNCT05537922
- Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLCNot yet recruitingNCT05534113Phase 2
- PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung CancerRecruitingNCT05533086
- Phase 1b/2 Study to Evaluate ABT-101 in Solid Tumor and NSCLC PatientsRecruitingNCT05532696Phase 1/2
- Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective StudyNot yet recruitingNCT05532527Not applicable
- Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib BloodlevelsRecruitingNCT05525338Phase 4
- Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung CancerRecruitingNCT05522660Phase 3
- Phase I/IIa Study of H002 in NSCLC With Active EGFR MutationRecruitingNCT05519293Phase 1/2
- Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C MutationRecruitingNCT05504278Phase 1
- Phase Ib/II Study of Almonertinib Combined With SHR-1701 in the Treatment of Relapsed or Advanced Non-small Cell Lung CancerNot yet recruitingNCT05503888Phase 1/2
- The Impact of Surgical Technique on Circulating Tumor DNA in Stage I-III Non-Small Cell Lung CancerRecruitingNCT05502523Not applicable
- Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung CancerRecruitingNCT05501665Phase 1/2
- A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerRecruitingNCT05498428Phase 2
- EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung CancerNot yet recruitingNCT05498389Phase 1/2
- A Real World Study of Ensartinib in Advanced ALK-positive NSCLCRecruitingNCT05498064
- Psychosocial eHealth in Advanced Lung CancerRecruitingNCT05497973Not applicable
- Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung CancerRecruitingNCT05493566Early Phase 1
- START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerRecruitingNCT05492682Phase 1
- VIC-1911 Combined With Osimertinib for EGFR -Mutant Non-small Cell Lung CancerRecruitingNCT05489731Phase 1
- A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-small Cell Lung Cancer After Complete Surgical Resection.RecruitingNCT05487391Phase 3
- ctDNA as a Biomarker for Treatment in Advanced NSCLCNot yet recruitingNCT05486988
- An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor TreatmentRecruitingNCT05486650
- Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation TherapyRecruitingNCT05468242Phase 2
- EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerRecruitingNCT05467748Phase 1/2
- Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRDRecruitingNCT05457049
- A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaRecruitingNCT05456256Phase 2
- Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung CancerRecruitingNCT05452005Phase 1
- Combining ICI With SBRT or HypoFrx-RT for ES NSCLCNot yet recruitingNCT05451173Phase 1/2
- An Open-label, Phase 2trial of Sotorasib in KRAS G12C-mutant Non-small-cell Lung Cancer(NSCLC) Patients and a Translational Study to Find Acquired Resistance Mechanism to SotorasibNot yet recruitingNCT05451056Phase 2
- Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR MutationsRecruitingNCT05445791Phase 3
- Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung CancerRecruitingNCT05445310Phase 2
- To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruitingNCT05442060Phase 2
- Significance of MRD After Surgery in Driver Gene-positive and Driver Gene-negative Stage IB-IIA NSCLCEnrolling by invitationNCT05441566
- Phase 1/2 Study of HS-10376 in Patients With Non-Small Cell Lung CancerRecruitingNCT05435274Phase 1/2
- Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)RecruitingNCT05435248Phase 1/2
- Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)RecruitingNCT05431270Phase 1/2
- Liver SBRT in Combination With Immune Checkpoint Inhibition in Patients With Metastatic Non-small Cell Lung CancerRecruitingNCT05430009Phase 1
- Neoadjuvant Therapy of Sintilimab Combined With Chemotherapy for Resectable Squamous Cell NSCLC（neoSCORE Ⅱ）RecruitingNCT05429463Phase 3
- Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung CancerRecruitingNCT05424029
- Observational Retro-prospective Study on PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLCRecruitingNCT05418660
- Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung CancerRecruitingNCT05416775Phase 1/2
- A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung CancerNot yet recruitingNCT05414630Phase 2
- Study of Osimertinib With Carotuximab in Advanced, EGFR-mutated Non-Small Cell Lung CancerRecruitingNCT05401110Phase 1
- Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapyRecruitingNCT05398094Phase 2
- A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLCRecruitingNCT05394831Phase 1/2
- BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Not yet recruitingNCT05393466Phase 1/2
- Immunonutrition for Improving the Efficacy of Immunotherapy in Patients With Metastatic Non-small Cell Lung CancerRecruitingNCT05384873Not applicable
- Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)RecruitingNCT05382728Phase 3
- Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLCNot yet recruitingNCT05380271Phase 2
- Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRecruitingNCT05379985Phase 1/2
- High-dose Furmonertinib for First-line Treatment of EGFR Mutated NSCLC With Central Nervous System (CNS) MetastasesRecruitingNCT05379803Phase 2
- The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?RecruitingNCT05378633Not applicable
- Efficacy and Safety of HGXJT in Bone Metastatic NSCLC PatientsRecruitingNCT05378334Not applicable
- AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung CancerRecruitingNCT05377658Phase 2
- A Clinical Study of LM103 Injection in the Treatment of Advanced Solid TumorsRecruitingNCT05366478Phase 1
- An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in EuropeRecruitingNCT05363319
- Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More TreatmentRecruitingNCT05363280Phase 2
- A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerRecruitingNCT05361174Phase 1/2
- A Clinical Study of Immunotherapy Combined With Chemotherapy and Anti-angiogenic Therapy in Operable NSCLCEnrolling by invitationNCT05360979Phase 2
- Multiomics Tumor Evolution Model of NSCLCRecruitingNCT05352035
- SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.RecruitingNCT05351788Phase 2
- WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLCRecruitingNCT05351320Phase 2
- Efficacy and Safety of Anti-PD-1/PD-L1 Treatment +/- UV1 Vaccination in Patients With Non-small Cell Lung CancerRecruitingNCT05344209Phase 2
- Ensartinib as Adjuvant Treatment in Anaplastic Lymphoma Kinase (ALK) Positive Non-small Cell Lung CancerRecruitingNCT05341583Phase 3
- Patient's Whole Process Follow-up Management(HOPE-1)RecruitingNCT05339568